As a kind of special product, drugs are strictly controlled by each country by means of admittance regulation—Drug Registration. For Chinese pharmaceutical enterprises, overseas drug registration is like a threshold, a dual threshold of technology and regulation, only those enterprises who cross the threshold could they obtain the legal identity in the overseas market and get good returns. However, less confidence on products quality and GMP management, worry about operation cost, absence of research and understanding on the laws and regulations of overseas registration, make lots of Chinese enterprises act as processors only and earn a little service fee.

    HUSTLIFE SCITECH formulates the product internationalization strategy since the establishment, it aims at international market at the very beginning and    internationalizes sales market by means of internationalizing quality standard and product registration, On one side, it relied on technical support of Huazhong University of Science & Technology, kept on improving product quality to the highest international standard, took great efforts to improve GMP management level, on the other side, it sought for cooperator actively, did plenty research on drug policies and regulations of overseas market, it acquired 5 overseas drug registration certificate within 3 years, and now HUSTLIFE SCITECH has entered into these markets successfully. With strong technical support, overseas registration advantage, superior quality and distinctive brand awareness, HUSTLIFE SCITECH gains identification from the customers overseas, so far the Hydroxyethyl Starch of HUSTLIFE SCITECH has entered into 14 countries and regions.

    European pharmacopeia, as one of the four international pharmacopeias, adopted Hydroxyethyl Starch firstly in its 7.0 version in June, 2010. More and more European customers approach us for cooperation, that’s how we decide to make a strategic plan to apply for CEP authentication and European GMP.

    Year 2013 is full of challenge and chance,   HUSTLIFE SCITECH will devote itself to developing European and American markets.